Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Microba Life Sciences Limited ( (AU:MAP) ) has issued an announcement.
Microba Life Sciences Limited announced the issuance of 46,296,296 unquoted equity securities, set to expire on January 13, 2027, as part of a transaction previously disclosed to the market. This issuance could impact the company’s financial structure and stakeholder interests by expanding its equity base.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.33 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Microba Life Sciences Limited operates in the biotechnology industry, focusing on microbiome analysis and related health solutions.
Average Trading Volume: 327,779
Technical Sentiment Signal: Sell
Current Market Cap: A$46.35M
Learn more about MAP stock on TipRanks’ Stock Analysis page.